Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
19.83
+0.03 (0.15%)
At close: Nov 13, 2026, 4:00 PM EST
19.83
0.00 (0.01%)
After-hours: Nov 13, 2026, 7:30 PM EST

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $465.83K in the twelve months ending September 30, 2026, down -98.14% year-over-year. In the year 2025, Silence Therapeutics had annual revenue of $568.83K, down -98.66%.

Revenue (ttm)
$465.83K
Revenue Growth
-98.14%
P/S Ratio
2,705.01
Revenue / Employee
$5,182
Employees
88
Market Cap
1.23B

Revenue Chart

Revenue by Geography

  • UK 43.11M 99.7%
  • Germany 144.00K 0.3%
Fiscal year ended Dec 31, 2024 See the full Silence Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025568.83K-41.89M-98.66%
Dec 31, 202442.45M10.81M34.17%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.87M29.01%
Dec 31, 202116.78M9.29M124.07%
Dec 31, 20207.49M7.17M2,215.11%
Dec 31, 2019323.57K--
Dec 31, 2018---
Dec 31, 201721.62K-928.69K-97.72%
Dec 31, 2016950.31K--
Dec 31, 2015---
Dec 31, 201423.37K-170.40K-87.94%
Dec 31, 2013193.77K-70.63K-26.71%
Dec 31, 2012264.40K-812.57K-75.45%
Dec 31, 20111.08M-2.61M-70.75%
Dec 31, 20103.68M893.28K32.03%
Dec 31, 20092.79M-435.52K-13.51%
Dec 31, 20083.22M--